Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

VNDA - Vanda Pharmaceuticals Inc

IEX Last Trade
5.28
0.060   1.136%

Share volume: 600,277
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$5.22
0.06
1.15%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
10%
Profitability 4%
Dept financing 4%
Liquidity 74%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.11%
1 Month
-9.42%
3 Months
5.59%
6 Months
18.34%
1 Year
-1.12%
2 Year
-51.65%
Key data
Stock price
$5.28
P/E Ratio 
-28.22
DAY RANGE
$5.17 - N/A
EPS 
-$0.19
52 WEEK RANGE
$3.30 - $6.75
52 WEEK CHANGE
$0.04
MARKET CAP 
308.353 M
YIELD 
N/A
SHARES OUTSTANDING 
58.290 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
BETA 
0.88
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$424,589
AVERAGE 30 VOLUME 
$519,115
Company detail
CEO: Mihael Polymeropoulos
Region: US
Website: http://www.vandapharma.com/
Employees: 346
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.

Recent news